Nathan R. Miselis

797 citations
10 papers · 465 indexed · h-index 7
Topics
DNA Repair Mechanisms (4 papers)CRISPR and Genetic Engineering (2 papers)Chronic Lymphocytic Leukemia Research (2 papers)

In The Last Decade

Nathan R. Miselis

10 papers receiving 453 citations

Peers

Nathan R. Miselis
Comparison fields: 5 of 70
  • Molecular Biology 246
  • Oncology 140
  • Pulmonary and Respiratory Medicine 94
  • Materials Chemistry 73
  • Immunology 64
Replace Julien Daubriac with:
Julien Daubriac United States
Thilo Papp Germany
Rolando André Rios Villacis Brazil
Kate Dudek United Kingdom
Shuangyin Han China
Pratima Basak United States
Laura Mitrofan France
Sara Galavotti United Kingdom
Chenjun Bai China
Annikka Linnala‐Kankkunen Finland
Nathan R. Miselis relative to Julien Daubriac United States Julien Daubriac's profile →
Citations per field
00.5×2.6×
Julien Daubriac · 1×
Citations per year

Countries citing papers authored by Nathan R. Miselis

Since Specialization
Citations

This map shows the geographic impact of Nathan R. Miselis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan R. Miselis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan R. Miselis more than expected).

Fields of papers citing papers by Nathan R. Miselis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan R. Miselis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan R. Miselis. The network helps show where Nathan R. Miselis may publish in the future.

Co-authorship network of co-authors of Nathan R. Miselis

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan R. Miselis. A scholar is included among the top collaborators of Nathan R. Miselis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan R. Miselis. Nathan R. Miselis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 2
2 5
3 1
4 65
5 10
6 134
7 83
8 85
9 41
10 39

About Nathan R. Miselis

Nathan R. Miselis is a scholar working on Oncology, Genetics and Biotechnology, having authored 10 papers that have together received 465 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (4 papers), CRISPR and Genetic Engineering (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Oncology (140 citations), Molecular Biology (246 citations) and Immunology (64 citations). Nathan R. Miselis has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include Agnes B. Kane, Howard L. Liber, Vanesa C. Sanchez, Jodie Pietruska, Robert H. Hurt, Zhijin Wu, Nico van Rooijen, Jac A. Nickoloff, Colin A. Bill and Yongjia Yu. Their work appears in journals such as Molecular and Cellular Biology, Cancer Research and Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026